Dr. Matthew Flick received an award from Glycos Biomedical Ltd. for his work entitled “GBM-1511 as Adjunctive Sepsis Therapeutic for Staphylococcus Aureus and Streptococcus Pneumonia”. Congratulations Dr. Flick!
Dr. Matthew Flick received an award from Glycos Biomedical Ltd. for his work entitled “GBM-1511 as Adjunctive Sepsis Therapeutic for Staphylococcus Aureus and Streptococcus Pneumonia”. Congratulations Dr. Flick!